NEXGEL Inc. (NXGLW)
0.36
-0.04 (-9.16%)
At close: Mar 28, 2025, 3:40 PM
Company Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels.
Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.
It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch.
The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019.
The company was founded in 1997 and is based in Langhorne, Pennsylvania.
NEXGEL Inc.
| Country | United States |
| IPO Date | n/a |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Adam R. Levy |
Contact Details
Address: 2150 Cabot Boulevard West Langhorne, Pennsylvania United States | |
| Website | https://nexgel.com |
Stock Details
| Ticker Symbol | NXGLW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001468929 |
| CUSIP Number | 65344E115 |
| ISIN Number | US65344E1156 |
| Employer ID | 26-4042544 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Adam R. Levy | Chief Executive Officer, President & Director |
| Joseph F. McGuire | Chief Financial Officer |
| Gregory Robb | Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | 10-K | Annual Report |
| Mar 25, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 8-K | Current Report |
| Mar 11, 2025 | 4 | Filing |
| Mar 05, 2025 | 4 | Filing |
| Feb 12, 2025 | 4 | Filing |
| Feb 12, 2025 | 4 | Filing |
| Feb 05, 2025 | 4 | Filing |
| Jan 22, 2025 | 8-K | Current Report |
| Jan 08, 2025 | 4 | Filing |